HIV Market Forecast: Industry Research Report

HIV Market Forecast

Published Date: June 2009

Published By: Datamonitor

Page Count: 264

Order Code: R313-52309

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Similar
Products

Introduction

In 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiation, decreasing mortality and an increase in HIV prevalence, a series of patent expiries will impact branded sales from 2011.

Reasons to Purchase

Understand the changing market dynamics of HIV drugs, success factors for leading brands and the commercial potential of late stage pipeline products
Assess the impact of events such as patent expiries and new product launches on individual brands and the overall antiretroviral market.
Obtain full global, country, class and product-specific forecasts of currently marketed and pipeline antiretrovirals from 2008 to 2018.

Please note: this is delivered as a Zip file.

Similar Products

• Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis

Published Nov 2009 by Aruvian's R'search

• Pharmaceuticals Industry Report

Published Nov 2009 by Plimsoll Publishing Ltd.

• Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes

Published Oct 2009 by Datamonitor

• Prescription Drug Wholesaling in the US - Industry Risk Rating Report

Published Oct 2009 by IBISWorld

• Antidepressants Market Forecast

Published Oct 2009 by Datamonitor